In one sentence
A narrative review of VR and AR in psychiatry reports strong evidence for anxiety/phobia treatments, solid PTSD exposure results, and encouraging autism-focused skill gains — while warning about small trials, short follow-up, and cybersickness.
What the researchers did
Authors synthesised systematic reviews, meta-analyses, and randomised trials on virtual reality (VR) and augmented reality (AR) in psychiatric care, drawing mainly from PubMed and Google Scholar plus landmark earlier papers. This is a narrative review across disorders, not a new autism-only meta-analysis.
What they found
- VR therapies show robust effects for anxiety disorders and phobias in meta-analytic evidence.
- For PTSD, VR exposure beat waitlist and looked comparable to established psychotherapies; AR exposure remains less studied.
- In autism, VR/AR interventions were reported to improve cognitive, social, and communication skills in reviewed trials.
- AR has been explored for cognitive assessment in Alzheimer’s disease; VR/AR rehab shows promise in ADHD and other neurodevelopmental conditions.
- Limits include small samples, short follow-up, heterogeneous protocols, and risks such as cybersickness or fatigue.
What this means for families and therapists
- VR can be a useful option for some anxiety and social-skill goals — not a replacement for environmental supports.
- Ask about evidence base, session length, cybersickness, and whether skills transfer outside the headset.
- Related reading: VR social skills review, anxiety guide, and social skills groups.
Limitations and what we don't know yet
- Narrative synthesis; quality of included autism trials varies.
- Long-term everyday transfer still under-studied.
- Access, cost, and clinic readiness limit routine use.
This is a plain-language summary of Digital Psychiatry with Virtual Reality and Augmented Reality: Recent Advances and Limitations by Chang J.H., Jang Y.J., Yoon S.C. et al., Clinical Psychopharmacology and Neuroscience (2026). Source license: CC-BY-NC-4.0. It is not medical advice — talk to a qualified clinician before changing therapy.